BRPI0816229A2 - Extratos com moduladores receptores x de fígado, compostos e seu uso especialmente no controle do peso. - Google Patents

Extratos com moduladores receptores x de fígado, compostos e seu uso especialmente no controle do peso.

Info

Publication number
BRPI0816229A2
BRPI0816229A2 BRPI0816229-8A BRPI0816229A BRPI0816229A2 BR PI0816229 A2 BRPI0816229 A2 BR PI0816229A2 BR PI0816229 A BRPI0816229 A BR PI0816229A BR PI0816229 A2 BRPI0816229 A2 BR PI0816229A2
Authority
BR
Brazil
Prior art keywords
liver
extracts
compounds
receptor modulators
weight control
Prior art date
Application number
BRPI0816229-8A
Other languages
English (en)
Inventor
Torsten Grothe
Ernst Roemer
Thomas Henkel
Original Assignee
Intermed Discovery Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermed Discovery Gmbh filed Critical Intermed Discovery Gmbh
Publication of BRPI0816229A2 publication Critical patent/BRPI0816229A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BRPI0816229-8A 2007-08-16 2008-07-29 Extratos com moduladores receptores x de fígado, compostos e seu uso especialmente no controle do peso. BRPI0816229A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07016037A EP2025335A1 (en) 2007-08-16 2007-08-16 Extracts with liver-X-receptor modulators, compounds and their use in weight control and treatment of disorders of lipid metabolism
PCT/EP2008/006226 WO2009021622A1 (en) 2007-08-16 2008-07-29 Extracts with liver-x-receptor modulators, compounds and their use especially in weight control

Publications (1)

Publication Number Publication Date
BRPI0816229A2 true BRPI0816229A2 (pt) 2015-06-16

Family

ID=39099916

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0816229-8A BRPI0816229A2 (pt) 2007-08-16 2008-07-29 Extratos com moduladores receptores x de fígado, compostos e seu uso especialmente no controle do peso.

Country Status (8)

Country Link
US (2) US20110213026A1 (pt)
EP (2) EP2025335A1 (pt)
JP (1) JP2010536720A (pt)
CN (1) CN101795678A (pt)
AU (1) AU2008286439A1 (pt)
BR (1) BRPI0816229A2 (pt)
WO (1) WO2009021622A1 (pt)
ZA (1) ZA201000644B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012045400A1 (en) * 2010-10-05 2012-04-12 Cognis Ip Management Gmbh An extract of the fruit of the plant schisandra chinensis
KR20120112137A (ko) * 2011-03-29 2012-10-11 서울대학교산학협력단 오미자 에틸아세테이트 분획물 또는 이로부터 분리한 우웨이지수 ｃ를 유효성분으로 포함하는 비만 예방 또는 치료용 조성물
WO2013112040A1 (en) 2012-01-27 2013-08-01 Biotropics Malaysia Berhad Use of certain trioxygenated benzene derivatives in body fat management
CN103751184B (zh) * 2014-01-09 2016-01-27 广东药学院 孕烷x受体拮抗剂在制备调脂与保肝产品中的应用
CN104892563B (zh) * 2014-03-06 2017-09-22 中国科学院大连化学物理研究所 一种细胞色素cyp3a4酶特异性探针反应及其应用
CN105949216A (zh) * 2016-05-20 2016-09-21 江苏神龙药业有限公司 一种塞来昔布的药物组合物及其新用途
CN106496245A (zh) * 2016-09-12 2017-03-15 南通市科通科技信息咨询有限公司 赖诺普利的药物组合物及其在生物医药中的应用
US20200188466A1 (en) * 2017-04-25 2020-06-18 Reyoung Corporation Compositions of schisandra extracts and methods thereof
CN111398454B (zh) * 2020-03-30 2022-07-05 青岛海洋生物医药研究院 一种抗肺癌海牡方指纹图谱的检测方法
CN111448988B (zh) * 2020-05-18 2021-08-13 江苏农林职业技术学院 抑制宝华玉兰初代培养内生菌污染的培养方法及培养基
TWI766295B (zh) 2020-06-17 2022-06-01 利統股份有限公司 一種草本組合物及其降尿酸、降低體脂肪及降低血糖之用途
CN113331422A (zh) * 2021-06-28 2021-09-03 海南净航科技发展有限公司 一种具有增强免疫力的保健功能的保健食品
CN114773446B (zh) * 2022-06-16 2022-11-04 中国农业科学院农业质量标准与检测技术研究所 一种蜂毒肽及其分离纯化方法
CN116008409B (zh) * 2022-09-30 2023-08-11 山东省食品药品检验研究院 一种鹿角胶特征图谱的构建方法及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61282315A (ja) * 1985-06-07 1986-12-12 Tsumura Juntendo Inc 肝不全症治療剤
JPS6222714A (ja) * 1985-07-22 1987-01-30 Tsumura Juntendo Inc 脂質代謝促進剤
JPH07101895A (ja) * 1993-09-30 1995-04-18 Tsumura & Co テトラヒドロジベンゾ［ａ，ｃ］シクロオクテン誘導体の製造法およびこれに用いる中間体
AU6209700A (en) * 1999-07-13 2001-01-30 Cedars-Sinai Medical Center Method and compositions for inhibiting biosynthesis or bioactivity of endogenoussteroid sex hormones in humans
US6495170B1 (en) * 2000-08-16 2002-12-17 N. V. Nutricia Method of increasing the presence of glutathione in cells
JP4104814B2 (ja) * 2000-09-22 2008-06-18 株式会社カネカ 配合食用油脂
KR100380634B1 (ko) * 2000-10-19 2003-04-26 주식회사 엘컴사이언스 디벤조사이클로옥탄계 리그난 화합물을 포함하는 퇴행성 뇌신경계 질환의 예방 또는 치료용 조성물
US6605305B2 (en) * 2001-04-04 2003-08-12 Xinxian Zhao Plant drug for treatment of liver disease
CN100482246C (zh) * 2001-10-30 2009-04-29 国家中药制药工程技术研究中心 一种用于治疗糖尿病的中药制剂及制备方法
JP3860133B2 (ja) * 2002-12-20 2006-12-20 株式会社東洋新薬 ダイエット食品
KR100572621B1 (ko) * 2003-03-19 2006-04-24 한국 한의학 연구원 비만 및 성인병 치료용 조성물
ES2384878T3 (es) * 2003-11-07 2012-07-13 Basf Beauty Care Solutions S.A.S. Uso cosmético de un extracto de la fruta de Schisandra chinensis
EP1532868B1 (de) * 2003-11-22 2009-03-11 Phytovisions GmbH & Co KG Pflanzenextrakte enthaltend Schisandra und Wolfsbeeren und Verfahren zu ihrer Herstellung
US20060062859A1 (en) * 2004-08-05 2006-03-23 Kenneth Blum Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes
JP4527524B2 (ja) * 2004-12-28 2010-08-18 花王株式会社 抗肥満物質のスクリーニング方法
US20090068281A1 (en) * 2005-03-29 2009-03-12 Koji Toyomura Composition, Functional Food and Pharmaceutical Composition for Improvement in Obesity
JP2007000081A (ja) * 2005-06-23 2007-01-11 Nichirei Foods:Kk 脂質代謝改善用食品
US20070269576A1 (en) * 2006-05-18 2007-11-22 Brent Barton Exotic fruit juice and silver-containing beverage

Also Published As

Publication number Publication date
US20130143959A1 (en) 2013-06-06
JP2010536720A (ja) 2010-12-02
EP2025335A1 (en) 2009-02-18
AU2008286439A1 (en) 2009-02-19
US20110213026A1 (en) 2011-09-01
CN101795678A (zh) 2010-08-04
EP2180889A1 (en) 2010-05-05
ZA201000644B (en) 2010-10-27
WO2009021622A1 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
BRPI0816229A2 (pt) Extratos com moduladores receptores x de fígado, compostos e seu uso especialmente no controle do peso.
BRPI0720003A2 (pt) pirimidinas substituídas e seu uso como moduladores de jnk
BRPI0814571A2 (pt) Compostos moduladores de fxr, seu uso e composição compreendendo os mesmos
BRPI0718192A2 (pt) Corantes dispersos, sua preparação e seu uso.
BRPI0815349A2 (pt) 6-amino-5-cloro-4-pirimidinacarboxilatos substituídos com 2-(2-fluorofeni-la) e seu uso como herbicidas
BRPI0808098A2 (pt) 4-aril-1,4-di-hidro-1,6-naftiridinamidas substituídas e seu uso
BRPI0821461A2 (pt) Uso de canabióides em combinação com um medicamento antipsicótico
BRPI1012209A2 (pt) descrição de composto de piridina e seu uso no controle de peste
AR079504A1 (es) Uso combinado de vip 3ab y cry1fa para el manejo de insectos resistentes
BRPI0817626A2 (pt) Ácidos 2-substituído-6-amino-5-alquil, alquenil ou alquinil-4-pirimidinacarboxílicos e ácidos 6-substituído-4-amino-3-alquil, alquenil ou aquinil picolínicos e seu uso como herbicidas
BRPI0923500A2 (pt) uso e composição farmacêutica compreendendo agonista ou modulador do receptor s1p, e kit.
BRPI0922296A2 (pt) Composições para o uso em recém-nascidos com baixo peso no nascimento.
BRPI0814931A2 (pt) Composto com atividade contra hcv, sua composição e seu uso
BRPI0911679A2 (pt) composto aciltiouréia, ou sal do mesmo, e seu uso
BRPI0919193A2 (pt) Uso de lipídeo, e, composição nutricional
BRPI0821027A2 (pt) 4-(4-ciano-2-tioaril) dihidropirimidinonas e seu uso
PT2687347T (pt) Decoração com material em pó
DK1981853T3 (da) Substituerede imidazoler samt anvendelse deraf som pesticider
BRPI0816372A2 (pt) Ácidos 6-fenilnicotínicos substituídos e seu uso
BRPI0816678A2 (pt) Composição que contém p-metano-3,8-diol e seu uso como repelente de insetos.
BRPI0914715A2 (pt) mistura, uso da mistura, e, filme retrátil.
BRPI0808846A2 (pt) fenoxifenilamidinas 3-substituídas e seu uso como fungicidas
BRPI0818641A2 (pt) Rótulo, e, uso do rótulo
BRPI0907254A2 (pt) Combinação biocida para uso em aplicações agrícolas
BRPI1014295A2 (pt) composição e seu uso, filme co-estrusado e artigo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.